2Gao Y,Zhao MH,Guo XH,et al.The prevalence and target antigens of anti-thyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism.Endocr.Res,2004,30:205-213.
3Slot MC,Links TP,Stegeman CA,et al.Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with anti-thyroid drugs:A long-term follow-up study.Arthritis Rheum,2005,53:108-113.
4Choi HK,Merkel PA,Walker AM,Niles JL.Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis:prevalence among patients with high titers of antimyeloperoxidase antibodies.Arthritis Rheum,2000,43:405 -413.
5Fujieda M,Hattori M,Kurayama H,et al.Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibodypositive glomerulonephritis associated with propylthiouracil treatment.J Am Soc Nephrol,2002,13:437 -445.
6Noh JY,Yasuda S,Sato S,et al.Clinical Characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs.J Clin Endocrinol Metab,2009,94:2806 -2811.
7Yu F,Chen M,Gao Y,et al.Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis.Am J Kidney Dis,2007,49:607-614.
8Noh JY,Asari T,Hamada N,et al.Frequency of appearance of myeloperoxidase-antineutrophil cytop lasmic antibody (MPO-ANCA)in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.Clin Endocrinol (Oxf),2001,54:651-654.
